No earnings within 2 weeks of this transaction.
| Insider | Schneider Eugene |
|---|---|
| Title | EVP, Chf Clinical Develop Ofcr |
| Transaction Date | Jan 2, 2026 |
| Exercise Date | Jan 2, 2027 |
| Expiration Date | Jan 1, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Non-Qualified Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Shares Purchased | 19,350 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 19,350 |
| Derivative | Derivative |
| Accession Number | 0000874015-26-000025 |
| Document | View SEC Filing |